News & Articles

Key opinion leaders’ expertise to guide design of new gene panels for GeneReader NGS

Prepare for the American Society for Mass Spectrometry(ASMS) Annual Meeting by discovering the many applications of mass spectrometry – from pesticide detection to imaging for cancer therapy

Actionable Insights Tumor Panel enables monitoring of cancer biomarkers from plasma samples

Future joint collaborations are expected as work continues to unlock the full clinical and research potential of both technologies

Reference data set from Horizon affirms proven accuracy of GeneReader workflow

Studies demonstrate pioneering research possible using ChIP technology

Win an Amazon voucher when you nominate your favorite clinical laboratory product

Horizon’s X-MAN cell lines to be made available in conjunction with Ubiquigent’s ubiquitin-related Drug Discovery Services

34-gene panel for assessing risk of 15 inherited cancers among new Quest Vantage™ test services to be highlighted during the 2016 ASCO Annual Meeting

Collaboration with Therawis addresses unmet need to guide clinical decisions in breast cancer

SelectScience® 'How To' Guides are independent resources written for scientists, by our editorial team

Discover how cutting edge technology is helping infectious disease laboratories to fight antibiotic resistance

Siemens Healthineers will expand its portfolio with molecular testing related services and technologies for oncology and genomics

Direct comparative studies now possible with a set of cancer-specific genes for DNA from tumor tissue or for circulating tumor DNA from liquid biopsy samples

Niguarda Hospital case study now available

A selection of interesting clinical diagnostic application articles

A look at some of the newest generation ‘load and go’ molecular microbiology analyzers

Life science companies combine expertise to enhance transcriptome research

Research published online in the International Journal of Cancer, shows the ParsortixTM System efficiently captures and harvests intact, viable circulating tumor cells (CTCs), including EpCAM-negative CTCs, to allow for broader downstream CTC analysis

Agena Bioscience to provide Horizon’s human genomic reference standards to assess quality and performance of oncology-based assays on the MassARRAY System

iPLEX® HS chemistry enables multiplex detection down to 1% allele frequency